Stocks
CYBN CorpCYBN
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders, including its lead candidate for generalized anxiety disorder. The company is advancing a pipeline of proprietary compounds through FDA-regulated trials, with investors tracking its progress in the emerging psychedelics research space.
Congressional Interest in CYBN Corp (CYBN)
No congressional trades have been disclosed for CYBN Corp (CYBN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CYBN?
No congressional trades found for this stock.